Skip to content

Clinical trials

Carcinoma, Medullary trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Medullary Country / region: South Korea Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20101
20111
20151
20172
20181
20192
20201
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting4
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Exelixis2
Boston Pharmaceuticals1
Genzyme, a Sanofi Company1
Hoffmann-La Roche1
Loxo Oncology, Inc.1
Novartis Pharmaceuticals1
Sanofi1
Turning Point Therapeutics, Inc.1
Yonsei University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Medullary12
Thyroid Neoplasms8
Carcinoma, Non-Small-Cell Lung5
Head and Neck Neoplasms4
Lung Neoplasms4
Thyroid Cancer, Papillary4
Bronchial Neoplasms3
Carcinoma, Bronchogenic3
Colonic Neoplasms3
Endocrine Gland Neoplasms3

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.